Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-5vg8p36Recruiting
Open-label, single-arm trial of benznidazole in American trypanosomiasis (CD), sponsored by Fundação Oswaldo Cruz. Primary endpoint: Benznidazole blood levels. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-5vg8p36.